All Industry articles – Page 11
View all stories with this category.
-
BusinessDuPont and Sumitomo link up for seed treatments
Firms will collaborate to develop and commercialise seed-applied technologies
-
Business
EU extends glyphosate licence by 5 years
Extending herbicide’s approval until December 2022 has pleased neither industry nor environmental campaigners
-
Business
Something fishy about eating insects
While insects as human food remain a novelty in the West, fly larvae grown on human food waste could soon become an important protein source for fish farms
-
Business
European drug regulator heads to Amsterdam
Brexit drives EMA to relocate, taking hundreds of jobs and significant expertise away from UK
-
Business
Russia backs new research cluster
Government touts high-tech science area as Russia’s answer to Silicon Valley
-
Opinion
Beyond buckets and batches
Embracing flow chemistry means leaving behind some faithful friends
-
-
Business
Targeting rare diseases
Is working on genetic mutations that affect only a few in every thousand people risky?
-
News
Republican tax bill backed by industry but not science
Chemical industry says tax overhaul will be fairer, but science groups warn that it will harm research
-
Business
China clamps down on polluting factories
Thousands of factories face closure or sanctions as authorities exercise new powers to curb air and water pollution
-
Business
China moves in on US shale gas
Alaska and West Virginia have welcomed investment from Chinese entities to develop US shale resources
-
Business
India's science start-ups
A growing community of entrepreneurs are overcoming cultural and infrastructure barriers to commercialise their research
-
Business
Chuck Norris versus gadolinium
US action star is suing 11 drug firms for $10m, claiming his wife was poisoned by gadolinium from her MRIs
-
Opinion
The value of quantification
A skills gap is emerging in organic synthesis that needs to be closed
-
Business
Valeant relinquishes female libido drug
Struggling firm is returning Sprout Pharmaceuticals subsidiary to original shareholders to resolve dispute over marketing
-
Business
Generics firms Amneal and Impax to merge
Deal continues consolidation trend, based on portfolio expansion and simplifying supply chains
-
Business
Novartis to buy AAA for radioligand cancer drugs
$3.9bn deal follows European approval of Advanced Accelerator Applications’ first-in-class radionuclide drug Lutathera
-
Business
ExxonMobil agrees to install pollution controls
Settlement with US government compels firm to improve emissions control and monitoring at eight chemical plants
-
Business
Lilly and CureVac to collaborate on mRNA cancer vaccines
Deal could see CureVac net up to $1.8 billion in upfront and milestone payments
-
Business
GSK’s shingles vaccine gets thumbs up in North America
Inoculation slated to be a blockbuster
